US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Eyetech Pharmaceuticals (MM) (EYET)
Eyetech Pharmaceuticals (MM) (EYET) ニュース

EYET

Eyetech (EYET)

Eyetech Pharmaceuticals (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:EYET

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2005/11/13	07 : 52	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/11/11	01 : 30	PR Newswire (US)	Eyetech Provides Update on Status of Pending Acquisition by OSI Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/11/01	07 : 00	PR Newswire (US)	Eyetech Reports Third Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/10/17	22 : 30	PR Newswire (US)	Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in Dia	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/10/05	22 : 30	PR Newswire (US)	Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients Wit	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/09/16	22 : 15	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/08/22	09 : 48	PR Newswire (US)	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement	NASDAQ:EYET
2005/08/22	08 : 45	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be Acc	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/08/09	22 : 30	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical Achievem	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/07/28	06 : 30	PR Newswire (US)	Eyetech Reports Second Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/07/19	03 : 30	PR Newswire (US)	Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists	NASDAQ:EYET
2005/07/16	02 : 30	PR Newswire (US)	Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/22	21 : 30	PR Newswire (US)	Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/22	04 : 33	PR Newswire (US)	Eyetech Vision Day to Preview Future of Macugen Franchise	NASDAQ:EYET
2005/06/14	08 : 34	PR Newswire (US)	Eyetech to Host Vision Day on Wednesday, June 22	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/11	06 : 29	Business Wire	Schaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/10	21 : 31	PR Newswire (US)	Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlin	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/09	21 : 30	PR Newswire (US)	Eyetech Adopts Stockholder Rights Agreement	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/25	10 : 30	PR Newswire (US)	Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/24	21 : 30	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/11	07 : 30	PR Newswire (US)	Eyetech to Present at the 2005 UBS Global Pharmaceuticals Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/06	06 : 10	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/05	23 : 19	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy Les	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/03	06 : 10	PR Newswire (US)	Preclinical Study Demonstrates Significance of VEGF164 in Pathological Neovascularization	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/03	06 : 10	PR Newswire (US)	Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMD	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/22	06 : 30	PR Newswire (US)	Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/21	07 : 09	PR Newswire (US)	Eyetech Reports First Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/08	06 : 30	PR Newswire (US)	Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/08	06 : 30	PR Newswire (US)	Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/03/19	06 : 15	PR Newswire (US)	Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)

Showing the most relevant articles for your search:NASDAQ:EYET

1 2 3 次へ >>

VanEck Investments

BNP Paribas Issuance

Cboe Vest Large Cap Deep...

FIP Endurance Debt

Invesco Wind Energy UCIT...

Societe Generale Effekten

Content Leaders Portfoli...

Yong Bai Chao New Retail (PK)

Caisse Francaise de Fina...

Vontobel Financial Produ...

Prominence Energy

Advanced Energy Industries

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約